38
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Extracellular aggregated alpha synuclein primarily triggers lysosomal dysfunction in neural cells prevented by trehalose

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Cell-to-cell propagation of aggregated alpha synuclein (aSyn) has been suggested to play an important role in the progression of alpha synucleinopathies. A critical step for the propagation process is the accumulation of extracellular aSyn within recipient cells. Here, we investigated the trafficking of distinct exogenous aSyn forms and addressed the mechanisms influencing their accumulation in recipient cells. The aggregated aSyn species (oligomers and fibrils) exhibited more pronounced accumulation within recipient cells than aSyn monomers. In particular, internalized extracellular aSyn in the aggregated forms was able to seed the aggregation of endogenous aSyn. Following uptake, aSyn was detected along endosome-to-lysosome and autophagosome-to-lysosome routes. Intriguingly, aggregated aSyn resulted in lysosomal activity impairment, accompanied by the accumulation of dilated lysosomes. Moreover, analysis of autophagy-related protein markers suggested decreased autophagosome clearance. In contrast, the endocytic pathway, proteasome activity, and mitochondrial homeostasis were not substantially affected in recipient cells. Our data suggests that extracellularly added aggregated aSyn primarily impairs lysosomal activity, consequently leading to aSyn accumulation within recipient cells. Importantly, the autophagy inducer trehalose prevented lysosomal alterations and attenuated aSyn accumulation within aSyn-exposed cells. Our study underscores the importance of lysosomes for the propagation of aSyn pathology, thereby proposing these organelles as interventional targets.

          Related collections

          Most cited references35

          • Record: found
          • Abstract: found
          • Article: not found

          Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein.

          Trehalose, a disaccharide present in many non-mammalian species, protects cells against various environmental stresses. Whereas some of the protective effects may be explained by its chemical chaperone properties, its actions are largely unknown. Here we report a novel function of trehalose as an mTOR-independent autophagy activator. Trehalose-induced autophagy enhanced the clearance of autophagy substrates like mutant huntingtin and the A30P and A53T mutants of alpha-synuclein, associated with Huntington disease (HD) and Parkinson disease (PD), respectively. Furthermore, trehalose and mTOR inhibition by rapamycin together exerted an additive effect on the clearance of these aggregate-prone proteins because of increased autophagic activity. By inducing autophagy, we showed that trehalose also protects cells against subsequent pro-apoptotic insults via the mitochondrial pathway. The dual protective properties of trehalose (as an inducer of autophagy and chemical chaperone) and the combinatorial strategy with rapamycin may be relevant to the treatment of HD and related diseases, where the mutant proteins are autophagy substrates.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.

            Lewy bodies (LBs) are hallmark lesions of degenerating neurons in the brains of patients with Parkinson's disease (PD) and dementia with Lewy bodies (DLB). Recently, a point mutation in the gene encoding the presynaptic alpha-synuclein protein was identified in some autosomal-dominantly inherited familial PD pedigrees, and light microscopic studies demonstrated alpha-synuclein immunoreactivity in LBs of sporadic PD and DLB. To characterize alpha-synuclein in LBs, we raised monoclonal antibodies (MAbs) to LBs purified from DLB brains and obtained a MAb specific for alpha-synuclein that intensely labeled LBs. Light and electron microscopic immunocytochemical studies performed with this MAb as well as other antibodies to alpha-and beta-synuclein showed that alpha-synuclein, but not beta-synuclein, is a component of LBs in sporadic PD and DLB. Western blot analyses of highly purified LBs from DLB brains showed that full-length as well as partially truncated and insoluble aggregates of alpha-synuclein are deposited in LBs. Thus, these data strongly implicate alpha-synuclein in the formation of LBs and the selective degeneration of neurons in sporadic PD and DLB.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Addition of exogenous α-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous α-synuclein to Lewy body and Lewy neurite-like aggregates.

              This protocol describes a primary neuronal model of formation of α-synuclein (α-syn) aggregates that recapitulate features of the Lewy bodies and Lewy neurites found in Parkinson's disease brains and other synucleinopathies. This model allows investigation of aggregate formation, their impact on neuron function, and development of therapeutics. Addition of preformed fibrils (PFFs) synthesized from recombinant α-syn to neurons seeds the recruitment of endogenous α-syn into aggregates characterized by detergent insolubility and hyperphosphorylation. Aggregate formation follows a lag phase of 2-3 d, followed by formation in axons by days 4-7, spread to somatodendritic compartments by days 7-10 and neuron death ~14 d after PFF addition. Here we provide methods and highlight the crucial steps for PFF formation, PFF addition to cultured hippocampal neurons and confirmation of aggregate formation. Neurons derived from various brain regions from nontransgenic and genetically engineered mice and rats can be used, allowing interrogation of the effect of specific genes on aggregate formation.
                Bookmark

                Author and article information

                Contributors
                wei.xiang@fau.de
                Journal
                Sci Rep
                Sci Rep
                Scientific Reports
                Nature Publishing Group UK (London )
                2045-2322
                24 January 2019
                24 January 2019
                2019
                : 9
                : 544
                Affiliations
                [1 ]ISNI 0000 0001 2107 3311, GRID grid.5330.5, Institute of Biochemistry, , Friedrich-Alexander-University Erlangen-Nürnberg (FAU), ; Erlangen, Germany
                [2 ]ISNI 0000 0000 9935 6525, GRID grid.411668.c, Division of Molecular Neurology, , University Hospital Erlangen, FAU Erlangen-Nürnberg, ; Erlangen, Germany
                [3 ]Center for Human Genetics Regensburg, Regensburg, Germany
                [4 ]ISNI 0000000123222966, GRID grid.6936.a, Department of Chemistry, , Technical University of Munich, ; Munich, Germany
                [5 ]ISNI 0000000121511713, GRID grid.10772.33, CEDOC, Chronic Diseases Research Center, NOVA Medical School | Faculdade de Ciências Médicas, , Universidade NOVA de Lisboa, ; Campo dos Mártires da Pátria, 130, 1169-056 Lisboa, Portugal
                [6 ]ISNI 0000 0001 2107 3311, GRID grid.5330.5, Division of Molecular Immunology, Nikolaus-Fiebiger-Center, Department of Internal Medicine III, , FAU Erlangen-Nürnberg, ; Erlangen, Germany
                Article
                35811
                10.1038/s41598-018-35811-8
                6345801
                30679445
                5c9f400b-7b48-41f5-8302-3a0b213d3f43
                © The Author(s) 2019

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 12 February 2018
                : 29 October 2018
                Funding
                Funded by: Fundação para a Ciência e Tecnologia (FCT), Portugal (SFRH/BPD/109347/ 2015; PTDC/NEU-OSD/5644/2014)
                Funded by: the Interdisciplinary Center for Clinical Research of the University Hospital Erlangen, Germany (E22)
                Funded by: FundRef https://doi.org/10.13039/501100001659, Deutsche Forschungsgemeinschaft (German Research Foundation);
                Award ID: KL1395/8-1
                Award ID: INST 410/45-1 FUGG
                Award Recipient :
                Funded by: The Interdisciplinary Center for Clinical Research of the University Hospital Erlangen, Germany, E11. Bavarian State Ministry of Education and Culture, Science and Arts, Bavarian Research Network for Induced Pluripotent Stem Cells-ForIPS.
                Funded by: Interdisciplinary Center for Clinical Research of the University Hospital Erlangen, Germany, E21. Bavarian State Ministry of Education and Culture, Science and Arts, Bavarian Research Network for Induced Pluripotent Stem Cells-ForIPS. Research Foundation Medicine, University Hospital Erlangen, Parkinson and Nutrition.
                Funded by: The Interdisciplinary Center for Clinical Research of the University Hospital Erlangen, Germany, E11. Johannes und Frieda Marohn-Stiftung, Germany, Project: Alpha-synuclein.
                Categories
                Article
                Custom metadata
                © The Author(s) 2019

                Uncategorized
                Uncategorized

                Comments

                Comment on this article